In patients with prostate cancer, the change in serum PGK1 level is closely related to the postoperative efficacy and survival of patients and has diagnostic value (Chen et al., 2018; Pérez-Gómez et al., 2023). This evidence concerns the gene PGK1 and Familial prostate cancer.